Skip to content

The Carlyle Group

US · CG #1171 by market cap Listed 1970
36.00 -1.67 -4.43%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • The Carlyle Group Options Spot-On: On November 19th, 117.35K Contracts Were Traded, With 116.87K Open Interest
    Market Newswire · 2026/11/20
  • Rating change
    Major Bank Ratings | UBS Group: Lowers Carlyle Target Price to $47, Downgrades Rating to “Neutral”
    Gelonghui Finance · 2026/11/11
  • Company notice
    RCECAP: Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - CG (L) FOUNDATION
    Bursa Malaysia · 2026/10/29
  • Rating change
    Carlyle Group Price Target Cut to $58.00/Share From $66.00 by Goldman Sachs
    Dow Jones · 2026/11/11
  • Rating change
    Morgan Stanley Maintains CG Oncology(CGON.US) With Buy Rating, Raises Target Price to $102
    Market Newswire · 2026/11/13
  • Rating change
    Morgan Stanley Maintains CG Oncology(CGON.US) With Buy Rating, Raises Target Price to $117
    Market Newswire · 2026/11/18
  • Company notice
    Dynamic Map Platform Co.,Ltd.: Dynamic Map Platform to Exhibit at Tokyo Game Show 2026; Engages in Information Exchange with 35 Domestic and International Companies in the Gaming, CG, and XR Sectors, Proposing the Utilization of Spatial Data for Games.
    JPX · 2026/9/25
  • The Carlyle Group To Go Ex-Dividend On November 16th, 2026 With 0.35 USD Dividend Per Share
    Market Newswire · 2026/11/13
  • Company notice
    4: Statement of changes in beneficial ownership of securities-10% Owner Carlyle Group Inc.
    SEC · 2026/11/20
  • Rating change
    A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $97 to $115
    Market Newswire · 2026/11/17
  • Company notice
    CG MedTech Co: Report on Status of Specific Securities, Etc. Owned by Executives and Major Shareholders
    OPENDART · 2026/10/15
  • Carlyle Group, CVC DIF Get EU Approval for BauWatch Acquisition
    MT Newswires · 2026/11/11
  • Rating change
    Wedbush Maintains CG Oncology(CGON.US) With Buy Rating, Raises Target Price to $91
    Market Newswire · 2026/11/17
  • Rating change
    Guggenheim Maintains CG Oncology(CGON.US) With Buy Rating, Raises Target Price to $120
    Market Newswire · 2026/11/19
  • Rating change
    Truist Financial Maintains CG Oncology(CGON.US) With Buy Rating, Announces Target Price $100
    Market Newswire · 2026/11/17
  • KKR and Carlyle Group Invest $475 Million in Litmus Music -- WSJ
    WSJ · 2026/11/18
  • Rating change
    Carlyle Group Is Maintained at Buy by Goldman Sachs
    Dow Jones · 2026/11/11
  • Rating change
    Carlyle Group Cut to Neutral From Buy by UBS
    Dow Jones · 2026/11/10
  • Goldman Sachs Maintains The Carlyle Group(CG.US) With Buy Rating, Cuts Target Price to $58
    Market Newswire · 2026/11/11
  • Company notice
    AMBANK: Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - CG (L) FOUNDATION
    Bursa Malaysia · 2026/10/29
  • The Carlyle Group To Go Ex-Dividend On November 16th, 2026 With 0.35 USD Dividend Per Share
    Market Newswire · 2026/11/7
  • Company notice
    CG MedTech Co: Report on Significant Holdings of Stocks, Etc. (General)
    OPENDART · 2026/9/11
  • Rating change
    Deutsche Bank Adjusts Carlyle Group Price Target to $48 From $51, Maintains Buy Rating
    MT Newswires · 2026/11/6
  • Evercore ISI Group Maintains In-Line on Carlyle Group, Lowers Price Target to $42
    Benzinga · 2026/11/6
  • Rating change
    Carlyle Group Is Maintained at Overweight by Piper Sandler
    Dow Jones · 2026/10/19

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:19 · For reference only, not investment advice and not tailored to your situation.

The Carlyle Group discussion 0 comments

Add a comment